Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Giaccone

Showing results (341-350 of 359) with videos related to

Pageof 36
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 5, 2002
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancerS M de Lange, C J van Groeningen, O W M Meijer, et al.
Seminars in Oncology|February 1, 1997
Clinical pharmacology of carboplatin administered in combination with paclitaxelL J van Warmerdam, M T Huizing, G Giaccone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2013
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancerR J Kelly, A Thomas, A Rajan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2008
Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizerJ Sigmond, R J Honeywell, T J Postma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2017
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumorsY J Bang, G Giaccone, S A Im, et al.
British Journal of Cancer|April 16, 2002
A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinomaA Baars, A M E Claessen, J Wagstaff, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 25, 2019
An atypical presentation of diffuse midline pontine glioma in a middle age patient: Case reportS Floro, D Belvedere, C Rosci, et al.
Clinical Immunology (Orlando, Fla.)|July 24, 2001
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damageH J van der Vliet, B M von Blomberg, N Nishi, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2003
Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumorsG J Peters, P Noordhuis, A B P Van Kuilenburg, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative GroupT Sahmoud, P E Postmus, C van Pottelsberghe, et al.
Pageof 36

Showing results (341-350 of 359) with videos related to

Sort By:
Pageof 36
European Journal of Cancer (Oxford, England : 1990)|June 5, 2002
Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancerS M de Lange, C J van Groeningen, O W M Meijer, et al.
Seminars in Oncology|February 1, 1997
Clinical pharmacology of carboplatin administered in combination with paclitaxelL J van Warmerdam, M T Huizing, G Giaccone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2013
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancerR J Kelly, A Thomas, A Rajan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2008
Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizerJ Sigmond, R J Honeywell, T J Postma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2017
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumorsY J Bang, G Giaccone, S A Im, et al.
British Journal of Cancer|April 16, 2002
A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinomaA Baars, A M E Claessen, J Wagstaff, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 25, 2019
An atypical presentation of diffuse midline pontine glioma in a middle age patient: Case reportS Floro, D Belvedere, C Rosci, et al.
Clinical Immunology (Orlando, Fla.)|July 24, 2001
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damageH J van der Vliet, B M von Blomberg, N Nishi, et al.
Cancer Chemotherapy and Pharmacology|May 10, 2003
Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumorsG J Peters, P Noordhuis, A B P Van Kuilenburg, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative GroupT Sahmoud, P E Postmus, C van Pottelsberghe, et al.
Pageof 36